Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The issue of renal safety of zoledronic acid from a nephrologist's point of view.

× No keyword cloud information.

5 in total

Review 1. Bisphosphonates for malignancy-related bone disease: current status, future developments.

Authors: Jean-Jacques Body
Journal: Support Care Cancer Date: 2006-02-01 Impact factor: 3.603

2. Bisphosphonate therapy in metastatic carcinoma patients with chronic renal failure: are bisphosphonates an enemy or crony?

Authors: Fatos Dilan Koseoglu; Cagatay Arslan
Journal: Support Care Cancer Date: 2015-03-13 Impact factor: 3.603

3. Renal safety of zoledronic acid administration beyond 24 months in breast cancer patients with bone metastases.

Authors: Murat Dincer; Kadri Altundag; Hakan Harputluoglu; Sercan Aksoy; Mustafa Cengiz; Ibrahim Gullu
Journal: Med Oncol Date: 2008-01-15 Impact factor: 3.064

Review 4. Tolerability of different dosing regimens of bisphosphonates for the treatment of osteoporosis and malignant bone disease.

Authors: Raja S Bobba; Karen Beattie; Bill Parkinson; Dinesh Kumbhare; Jonathan D Adachi
Journal: Drug Saf Date: 2006 Impact factor: 5.228

5. A modified method for reducing renal injury in zoledronic Acid treatment of hypercalcemia and adverse skeletal events.

Authors: Jiang Liu; Liqun Zheng; Wenhua Zhang; Keli Chang; Yan Pang
Journal: Indian J Palliat Care Date: 2013-01

5 in total